Veer Bhavnagri

Insider Reports History

Location
South San Francisco, CA
Signature
/s/Veer Bhavnagri
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Veer Bhavnagri:

Company Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. General Counsel Common Stock 556,049 $1,765,122 $3.17 14 Mar 2023 Direct

Insider Reports Filed by Veer Bhavnagri

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALLO Allogene Therapeutics, Inc. 14 Mar 2023 1 -$133,971 4 General Counsel 16 Mar 2023, 16:46
ALLO Allogene Therapeutics, Inc. 13 Feb 2023 1 -$20,550 4 General Counsel 14 Feb 2023, 16:10
ALLO Allogene Therapeutics, Inc. 17 Jan 2023 1 -$21,120 4 General Counsel 18 Jan 2023, 17:10
ALLO Allogene Therapeutics, Inc. 15 Dec 2022 1 -$42,186 4 General Counsel 19 Dec 2022, 15:29
ALLO Allogene Therapeutics, Inc. 23 Mar 2022 2 $0 4 General Counsel 25 Mar 2022, 17:49
ALLO Allogene Therapeutics, Inc. 15 Mar 2022 1 -$67,962 4 General Counsel 17 Mar 2022, 17:59
ALLO Allogene Therapeutics, Inc. 15 Sep 2021 3 -$112,494 4 General Counsel 17 Sep 2021, 16:44
ALLO Allogene Therapeutics, Inc. 16 Aug 2021 3 -$93,644 4 General Counsel 17 Aug 2021, 16:05
ALLO Allogene Therapeutics, Inc. 15 Jul 2021 3 -$96,403 4 General Counsel 16 Jul 2021, 16:14
ALLO Allogene Therapeutics, Inc. 15 Jun 2021 3 -$115,250 4 General Counsel 16 Jun 2021, 17:00
ALLO Allogene Therapeutics, Inc. 18 May 2021 3 -$138,650 4 General Counsel 20 May 2021, 17:19
ALLO Allogene Therapeutics, Inc. 17 May 2021 3 -$130,126 4 General Counsel 17 May 2021, 17:16